SAVIENT AUDIT COMMITTEE COMPLETES REVIEW

Savient Pharmaceuticals, Inc., an emerging specialty pharmaceuticals company focused on developing, manufacturing and marketing novel therapeutic products for unmet medical needs, announced today that its Audit Committee has completed its review and investigation, with the assistance of management, counsel and independent accounting consultants, of the facts and circumstances that contributed to an error in recording the Company's reserve for product returns.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1078926XSL_NEWSML_TO_NEWSML_WEB.xml)